Obsidian Therapeutics
OBX13.9400.07% ( +0.010 )
已收盘: 10月22日 16:00:00 (美东)全部股东
股东类型
- 公众及其他65.43%
- 机构投资者13.65%
- 风投/私募11.89%
- 对冲基金6.64%
- 个人与内部人士2.39%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
RA Capital Management, L.P. | 6.77% | 418.13 万 | -- | +418.13 万 | |
Paradigm Biocapital Advisors LP | 6.64% | 410.16 万 | -- | +410.16 万 | |
Atlas Venture Advisors, Inc. | 5.12% | 316.08 万 | -- | +316.08 万 | |
Vanguard Capital Management, LLC | 4.42% | 273.24 万 | -- | +273.24 万 | |
Deep Track Capital, LP | 3.77% | 232.72 万 | -- | +232.72 万 | |
Novo Holdings A/S | 3.55% | 219.27 万 | -- | +219.27 万 | |
Madan JagasiaPresident, CEO & Director | 1.46% | 90.35 万 | -- | +90.35 万 | |
Franklin Templeton Inc. | 1.35% | 83.33 万 | -- | +83.33 万 | |
Charles Schwab Investment Management, Inc. | 0.44% | 26.91 万 | -- | +26.91 万 | |
Parameswaran HariChief Medical Officer | 0.37% | 23.02 万 | -- | +23.02 万 | |
Dana AlexanderChief Technical Officer | 0.24% | 14.61 万 | -- | +14.61 万 | |
Maria FardisExecutive Chairman of the Board | 0.16% | 9.75 万 | -- | +9.75 万 | |
BlackRock, Inc. | 0.10% | 6.17 万 | -- | +6.17 万 | |
Robert RossIndependent Director | 0.07% | 4.33 万 | -- | +4.33 万 | |
Heidi HagenIndependent Director | 0.06% | 3.59 万 | -- | +3.59 万 | |
Matthew NorkunasIndependent Director | 0.03% | 1.98 万 | -- | +1.98 万 | |
Geode Capital Management, LLC | 0.03% | 1.65 万 | -- | +1.65 万 | |
T. Rowe Price Group, Inc. | <0.01% | 635.00 | -- | +635.00 |